ZHANG Li, ZHANG Guo-chun. Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
|
Citation:
|
ZHANG Li, ZHANG Guo-chun. Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
|
ZHANG Li, ZHANG Guo-chun. Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
|
Citation:
|
ZHANG Li, ZHANG Guo-chun. Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
|
DownLoad: